These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The action mechanism of brefeldin A. I. Growth recovery of Candida albicans by lipids from the action of brefeldin A. Hayashi T; Takatsuki A; Tamura G J Antibiot (Tokyo); 1974 Jan; 27(1):65-72. PubMed ID: 4601988 [No Abstract] [Full Text] [Related]
4. Antifungal efficiency of miconazole and econazole and the interaction with transport protein: a comparative study. Hu Z; Zhang J; Cheng X Pharm Biol; 2015 Feb; 53(2):251-61. PubMed ID: 25376919 [TBL] [Abstract][Full Text] [Related]
5. Antagonistic action of lipid components of membranes from Candida albicans and various other lipids on two imidazole antimycotics, clotrimazole and miconazole. Yamaguchi H Antimicrob Agents Chemother; 1977 Jul; 12(1):16-25. PubMed ID: 329757 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368 [TBL] [Abstract][Full Text] [Related]
7. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309 [TBL] [Abstract][Full Text] [Related]
8. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. Hirasawa M; Takada K J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042 [TBL] [Abstract][Full Text] [Related]
9. Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs. Beggs WH Mycopathologia; 1992 Dec; 120(3):131-2. PubMed ID: 1494356 [No Abstract] [Full Text] [Related]
10. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818 [TBL] [Abstract][Full Text] [Related]
11. Synergy of lysozyme and lanoconazole on the morphology of Candida albicans. Nishiyama Y; Nakaoka C; Hiratani T; Abe S; Uchida K; Yamaguchi H J Electron Microsc (Tokyo); 2001; 50(1):41-9. PubMed ID: 11291959 [TBL] [Abstract][Full Text] [Related]
12. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study. Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230 [TBL] [Abstract][Full Text] [Related]
13. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans. Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263 [TBL] [Abstract][Full Text] [Related]
14. Influence of lipid composition on the sensitivity of Candida albicans to antifungal agents. Mago N; Khuller GK Indian J Biochem Biophys; 1989 Feb; 26(1):30-3. PubMed ID: 2673990 [TBL] [Abstract][Full Text] [Related]
15. Sertaconazole: in-vitro antifungal activity against vaginal and other superficial yeast isolates. Carrillo-Muñoz AJ; Brió S; Quindós G; Palacín C; Guglietta A; Espinel-Ingroff A J Chemother; 2001 Oct; 13(5):555-62. PubMed ID: 11760221 [TBL] [Abstract][Full Text] [Related]
16. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. Wei GX; Xu X; Wu CD Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859 [TBL] [Abstract][Full Text] [Related]
17. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)]. Haller I Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473 [No Abstract] [Full Text] [Related]
18. In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. Sigle HC; Schäfer-Korting M; Korting HC; Hube B; Niewerth M Mycoses; 2006 May; 49(3):159-68. PubMed ID: 16681805 [TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344 [TBL] [Abstract][Full Text] [Related]
20. Synergistic mutual potentiation of antifungal activity of Zuccagnia punctata Cav. and Larrea nitida Cav. extracts in clinical isolates of Candida albicans and Candida glabrata. Butassi E; Svetaz LA; Ivancovich JJ; Feresin GE; Tapia A; Zacchino SA Phytomedicine; 2015 Jun; 22(6):666-78. PubMed ID: 26055132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]